Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin Interferon Alfa-2b vs PEG-IFN Alfa-2a in Chronic Hepatitis C Genotype 1
NCT00402428Phase 3Completed
- Sponsor
- Human Genome Sciences
- Start
- Dec 2006
- Primary completion
- Feb 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 15
01
Overview
A Phase 3 trial of albinterferon alfa-2b in hepatitis C (HCV), sponsored by Human Genome Sciences. Started Dec 2006; status: completed.
02
Drugs
albinterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00402428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402428.